 | • レポートコード：GIR-107A14944 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、シクレソニドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。シクレソニドの種類別市場規模（吸入エアロゾル37mcg/作動、吸入エアロゾル80mcg/作動、吸入エアロゾル120mcg/作動、吸入エアロゾル160mcg/作動）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・シクレソニドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Covis Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：吸入エアロゾル37mcg/作動、吸入エアロゾル80mcg/作動、吸入エアロゾル120mcg/作動、吸入エアロゾル160mcg/作動 ・用途別分析2016年-2026年：大人、子供 ・シクレソニドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・シクレソニドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・シクレソニドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・シクレソニドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・シクレソニドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ciclesonide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ciclesonide size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Ciclesonide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Ciclesonide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation
Market segment by Application, can be divided into
Adults
Children
Market segment by players, this report covers
Covis Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Ciclesonide
1.2 Classification of Ciclesonide by Type
1.2.1 Overview: Global Ciclesonide Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Ciclesonide Revenue Market Share by Type in 2020
1.2.3 Inhalation Aerosol 37 mcg/actuation
1.2.4 Inhalation Aerosol 80 mcg/actuation
1.2.5 Inhalation Aerosol 120 mcg/actuation
1.2.6 Inhalation Aerosol 160 mcg/actuation
1.3 Global Ciclesonide Market by Application
1.3.1 Overview: Global Ciclesonide Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Ciclesonide Market Size & Forecast
1.5 Global Ciclesonide Market Size and Forecast by Region
1.5.1 Global Ciclesonide Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Ciclesonide Market Size by Region, (2016-2021)
1.5.3 North America Ciclesonide Market Size and Prospect (2016-2026)
1.5.4 Europe Ciclesonide Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Ciclesonide Market Size and Prospect (2016-2026)
1.5.6 South America Ciclesonide Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Ciclesonide Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ciclesonide Market Drivers
1.6.2 Ciclesonide Market Restraints
1.6.3 Ciclesonide Trends Analysis
2 Company Profiles
2.1 Covis Pharma
2.1.1 Covis Pharma Details
2.1.2 Covis Pharma Major Business
2.1.3 Covis Pharma Ciclesonide Product and Solutions
2.1.4 Covis Pharma Ciclesonide Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Covis Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ciclesonide Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Ciclesonide Players Market Share
3.2.2 Top 10 Ciclesonide Players Market Share
3.2.3 Market Competition Trend
3.3 Ciclesonide Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ciclesonide Revenue and Market Share by Type (2016-2021)
4.2 Global Ciclesonide Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Ciclesonide Revenue Market Share by Application (2016-2021)
5.2 Ciclesonide Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Ciclesonide Revenue by Type (2016-2026)
6.2 North America Ciclesonide Revenue by Application (2016-2026)
6.3 North America Ciclesonide Market Size by Country
6.3.1 North America Ciclesonide Revenue by Country (2016-2026)
6.3.2 United States Ciclesonide Market Size and Forecast (2016-2026)
6.3.3 Canada Ciclesonide Market Size and Forecast (2016-2026)
6.3.4 Mexico Ciclesonide Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Ciclesonide Revenue by Type (2016-2026)
7.2 Europe Ciclesonide Revenue by Application (2016-2026)
7.3 Europe Ciclesonide Market Size by Country
7.3.1 Europe Ciclesonide Revenue by Country (2016-2026)
7.3.2 Germany Ciclesonide Market Size and Forecast (2016-2026)
7.3.3 France Ciclesonide Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Ciclesonide Market Size and Forecast (2016-2026)
7.3.5 Russia Ciclesonide Market Size and Forecast (2016-2026)
7.3.6 Italy Ciclesonide Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ciclesonide Revenue by Type (2016-2026)
8.2 Asia-Pacific Ciclesonide Revenue by Application (2016-2026)
8.3 Asia-Pacific Ciclesonide Market Size by Region
8.3.1 Asia-Pacific Ciclesonide Revenue by Region (2016-2026)
8.3.2 China Ciclesonide Market Size and Forecast (2016-2026)
8.3.3 Japan Ciclesonide Market Size and Forecast (2016-2026)
8.3.4 South Korea Ciclesonide Market Size and Forecast (2016-2026)
8.3.5 India Ciclesonide Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Ciclesonide Market Size and Forecast (2016-2026)
8.3.7 Australia Ciclesonide Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Ciclesonide Revenue by Type (2016-2026)
9.2 South America Ciclesonide Revenue by Application (2016-2026)
9.3 South America Ciclesonide Market Size by Country
9.3.1 South America Ciclesonide Revenue by Country (2016-2026)
9.3.2 Brazil Ciclesonide Market Size and Forecast (2016-2026)
9.3.3 Argentina Ciclesonide Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ciclesonide Revenue by Type (2016-2026)
10.2 Middle East & Africa Ciclesonide Revenue by Application (2016-2026)
10.3 Middle East & Africa Ciclesonide Market Size by Country
10.3.1 Middle East & Africa Ciclesonide Revenue by Country (2016-2026)
10.3.2 Turkey Ciclesonide Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Ciclesonide Market Size and Forecast (2016-2026)
10.3.4 UAE Ciclesonide Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Ciclesonide Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Ciclesonide Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Ciclesonide Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Ciclesonide Revenue (USD Million) by Region (2016-2021)
Table 5. Global Ciclesonide Revenue Market Share by Region (2021-2026)
Table 6. Covis Pharma Corporate Information, Head Office, and Major Competitors
Table 7. Covis Pharma Major Business
Table 8. Covis Pharma Ciclesonide Product and Solutions
Table 9. Covis Pharma Ciclesonide Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Ciclesonide Revenue (USD Million) by Players (2019-2021)
Table 11. Global Ciclesonide Revenue Share by Players (2019-2021)
Table 12. Breakdown of Ciclesonide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Ciclesonide Players Head Office, Products and Services Provided
Table 14. Ciclesonide Mergers & Acquisitions in the Past Five Years
Table 15. Ciclesonide New Entrants and Expansion Plans
Table 16. Global Ciclesonide Revenue (USD Million) by Type (2016-2021)
Table 17. Global Ciclesonide Revenue Share by Type (2016-2021)
Table 18. Global Ciclesonide Revenue Forecast by Type (2021-2026)
Table 19. Global Ciclesonide Revenue by Application (2016-2021)
Table 20. Global Ciclesonide Revenue Forecast by Application (2021-2026)
Table 21. North America Ciclesonide Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Ciclesonide Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Ciclesonide Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Ciclesonide Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Ciclesonide Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Ciclesonide Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Ciclesonide Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Ciclesonide Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Ciclesonide Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Ciclesonide Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Ciclesonide Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Ciclesonide Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Ciclesonide Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Ciclesonide Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Ciclesonide Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Ciclesonide Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Ciclesonide Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Ciclesonide Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Ciclesonide Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Ciclesonide Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Ciclesonide Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Ciclesonide Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Ciclesonide Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Ciclesonide Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Ciclesonide Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Ciclesonide Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Ciclesonide Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Ciclesonide Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Ciclesonide Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Ciclesonide Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Ciclesonide Picture
Figure 2. Global Ciclesonide Revenue Market Share by Type in 2020
Figure 3. Inhalation Aerosol 37 mcg/actuation
Figure 4. Inhalation Aerosol 80 mcg/actuation
Figure 5. Inhalation Aerosol 120 mcg/actuation
Figure 6. Inhalation Aerosol 160 mcg/actuation
Figure 7. Ciclesonide Revenue Market Share by Application in 2020
Figure 8. Adults Picture
Figure 9. Children Picture
Figure 10. Global Ciclesonide Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Ciclesonide Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Ciclesonide Revenue Market Share by Region (2016-2026)
Figure 13. Global Ciclesonide Revenue Market Share by Region in 2020
Figure 14. North America Ciclesonide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Ciclesonide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Ciclesonide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Ciclesonide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Ciclesonide Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Ciclesonide Market Drivers
Figure 20. Ciclesonide Market Restraints
Figure 21. Ciclesonide Market Trends
Figure 22. Covis Pharma Recent Developments and Future Plans
Figure 23. Global Ciclesonide Revenue Share by Players in 2020
Figure 24. Ciclesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 25. Global Top 3 Players Ciclesonide Revenue Market Share in 2020
Figure 26. Global Top 10 Players Ciclesonide Revenue Market Share in 2020
Figure 27. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 28. Global Ciclesonide Revenue Share by Type in 2020
Figure 29. Global Ciclesonide Market Share Forecast by Type (2021-2026)
Figure 30. Global Ciclesonide Revenue Share by Application in 2020
Figure 31. Global Ciclesonide Market Share Forecast by Application (2021-2026)
Figure 32. North America Ciclesonide Sales Market Share by Type (2016-2026)
Figure 33. North America Ciclesonide Sales Market Share by Application (2016-2026)
Figure 34. North America Ciclesonide Revenue Market Share by Country (2016-2026)
Figure 35. United States Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Canada Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Mexico Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Europe Ciclesonide Sales Market Share by Type (2016-2026)
Figure 39. Europe Ciclesonide Sales Market Share by Application (2016-2026)
Figure 40. Europe Ciclesonide Revenue Market Share by Country (2016-2026)
Figure 41. Germany Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. France Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. United Kingdom Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Russia Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Italy Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Ciclesonide Sales Market Share by Type (2016-2026)
Figure 47. Asia-Pacific Ciclesonide Sales Market Share by Application (2016-2026)
Figure 48. Asia-Pacific Ciclesonide Revenue Market Share by Region (2016-2026)
Figure 49. China Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Japan Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. South Korea Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. India Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Southeast Asia Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Australia Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South America Ciclesonide Sales Market Share by Type (2016-2026)
Figure 56. South America Ciclesonide Sales Market Share by Application (2016-2026)
Figure 57. South America Ciclesonide Revenue Market Share by Country (2016-2026)
Figure 58. Brazil Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Argentina Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Middle East and Africa Ciclesonide Sales Market Share by Type (2016-2026)
Figure 61. Middle East and Africa Ciclesonide Sales Market Share by Application (2016-2026)
Figure 62. Middle East and Africa Ciclesonide Revenue Market Share by Country (2016-2026)
Figure 63. Turkey Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Saudi Arabia Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. UAE Ciclesonide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Methodology
Figure 67. Research Process and Data Source
世界の吸入カプセル市場 2021：企業別、地域別、種類・用途別 The Inhalation Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界の作動用付属品市場 2021：企業別、地域別、種類・用途別 The Actuation Accessories market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の油圧式航空機用シート作動システム市場 2021：企業別、地域別、種類・用途別 The Hydraulic Aircraft Seat Actuation System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の吸入麻酔約薬市場 2021：企業別、地域別、種類・用途別 The Inhalation Anesthesia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の吸入チャンバー市場 2021：企業別、地域別、種類・用途別 The Inhalation Chambers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…